Skyhawk Therapeutics Revenue and Competitors

Boston, MA USA

Location

$181.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Skyhawk Therapeutics's estimated annual revenue is currently $5.5M per year.(i)
  • Skyhawk Therapeutics's estimated revenue per employee is $77,500
  • Skyhawk Therapeutics's total funding is $181.2M.

Employee Data

  • Skyhawk Therapeutics has 71 Employees.(i)
  • Skyhawk Therapeutics grew their employee count by -94% last year.

Skyhawk Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder, CEO & ChairmanReveal Email/Phone
2
Co-founder and CSO at Skyhawk TherapeuticsReveal Email/Phone
3
SVP ChemistryReveal Email/Phone
4
SVP, Nonclinical DevelopmentReveal Email/Phone
5
Head Business DevelopmentReveal Email/Phone
6
VP LegalReveal Email/Phone
7
SVP, Discovery BiologyReveal Email/Phone
8
ControllerReveal Email/Phone
9
Director, Medicinal ChemistryReveal Email/Phone
10
Director ChemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Skyhawk Therapeutics?

Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted towards cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.

keywords:N/A

$181.2M

Total Funding

71

Number of Employees

$5.5M

Revenue (est)

-94%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Skyhawk Therapeutics News

2022-03-30 - RNA-Targeted Small Molecules Market Size 2022, CAGR Value, Top Key Players, Competitive Landscape and Recent

... H3 Biomedicine Inc., Novartis AG, PTC Therapeutics, Ribometrix, SERVIER LABORATORIES, Skyhawk Therapeutics, , Other Market Participants.

2018-06-26 - Skyhawk Therapeutics Raises $40M in Equity Funding Round

Skyhawk Therapeutics, Inc., a Cambridge, Mass.-based drug development company, closed a new $40m equity investment round alongside its recently announced $60m strategic collaboration. This brings total new capital into the company to over $100m. Participants in the all-common stock equity round ...

2018-06-26 - Skyhawk Therapeutics Announces $40 Million Equity Investment Round

Skyhawk Therapeutics, Inc., today announced the closing of a new $40 million equity investment round alongside its recently announced $60 million strategic collaboration, bringing total new capital into the company to over $100 million. Proceeds will be used for development of Skyhawk's innovati ...

2018-01-24 - Skyhawk Therapeutics Raises $8M in Seed Financing

Skyhawk Therapeutics, Inc., a Waltham, Mass.-based company focused on the discovery and development of small molecule therapeutics that correct RNA expression, closed $8m seed funding round. The round was led by major family and biotech investors, including Tim Disney, the Duke of Bedford, Alex ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.3M7113%$1.7M
#2
$21.7M73-28%N/A
#3
$11.3M7311%N/A
#4
$3.5M74-4%N/A
#5
$11.5M7419%N/A